T1	p 65 88	severe bronchiectasis .
T2	p 156 170	bronchiectasis
T3	p 433 500	Twenty-four patients ( 12 female ; mean age 51 yr ) were randomized
T4	p 1469 1485	bronchiectasis .
T5	i 14 25	fluticasone
T6	i 98 120	corticosteroid therapy
T7	i 316 334	placebo-controlled
T8	i 401 412	fluticasone
T9	i 523 542	inhaled fluticasone
T10	i 612 621	placebo .
T11	i 979 990	fluticasone
T12	i 1007 1018	fluticasone
T13	i 1041 1048	placebo
T14	o 34 61	sputum inflammatory indices
T15	o 216 250	inflammatory and infective markers
T16	o 638 718	spirometry , 24-h sputum volume , sputum leukocyte density , bacterial densities
T17	o 725 819	concentrations of interleukin ( IL ) -1beta , IL-8 , tumor necrosis factor-alpha ( TNF-alpha )
T18	o 826 849	leukotriene B4 ( LTB4 )
T19	o 917 941	sputum leukocyte density
T20	o 946 961	IL-1beta , IL-8
T21	o 968 972	LTB4
T22	o 1073 1087	exacerbation .
T23	o 1125 1135	spirometry
T24	o 1165 1182	adverse reactions
T25	o 1288 1315	sputum inflammatory indices